 |
市場調査レポート
摂取型センサーの世界市場 - 成長、動向、予測Ingestible Sensors Market - Growth, Trends, and Forecast (2019 - 2024) |
||||||
| 発行 | Mordor Intelligence LLP | 商品コード | 704862 | ||||
| 出版日 | ページ情報 | 英文 111 Pages 納期: 2-3営業日 |
|||||
| 価格 |
|
||||||
| 摂取型センサーの世界市場 - 成長、動向、予測 Ingestible Sensors Market - Growth, Trends, and Forecast (2019 - 2024) | ||
| 出版日: 2019年03月01日 | ページ情報: 英文 111 Pages |
|
摂取型センサー市場は、予測期間（2018年〜2023年）に20.06％以上のCAGRで成長する見込みです。過去5年間にわたり、医療業界は、ウェアラブルおよび埋め込み型技術のような技術革新によって成長が推進されてきました。摂取型センサーは、医療分野における革新であり、急速に重要性を増しているデジタル医薬品（スマートピル）の構成要素です。医療分野のセンサーは、病状を治療する一環として、患者の生活習慣行動を理解するために主に使用されています。摂取型センサーは、ヘルスケア部門の主目的をサポートすることは別として、スマートピル技術に導入されることによって遠隔患者モニタリングの余地を作り出しています。
当レポートでは、世界の摂取型センサー市場を調査し、全体的な市場動向、タイプ・アプリケーション・エンドユーザー・地域別の詳細動向、市場成長への影響要因の分析、競合情勢、主要企業のプロファイルなどを包括的にまとめています。
The global ingestible sensors market is expected to witness a CAGR of 19.7% during the forecast period. Certain factors that are driving the market growth include increasing demand for medical adherence monitoring, cost-effectiveness, the availability of reimbursements, technological advancements, and growing investments.
In the field of healthcare, ingestible sensors are used in patient monitoring, capsule endoscopy, and controlled drug delivery applications. Sensors for other diagnostic purposes, such as temperature sensors that can wirelessly transmit the core body temperature as it travels through the digestive tract, are also available in the market.
Chronic diseases demand unremitting adherence to medications and Unfortunately, the rates of adherence fluctuate widely across patients. Hence, effective patient monitoring and event marking, such as the dissolution of drugs, becomes imperative, especially in the case of drugs having severe side effects. Therefore, the global market for ingestible sensors is growing rapidly, as the adoption rates of new healthcare technology are ever increasing, and the need for better patient monitoring is higher than ever.
As per the scope of the report, ingestible sensors include recently approved event markers, adherence monitoring, and digital medicine systems such as Otsuka and Proteus' Abilify MyCite tablet sensors, along with established modalities like capsule endoscopes and accompanying accessories. The ingestible sensor market is segmented on the basis of Component, Sensor Type, and Application, with each segment being further subdivided into subsegments like sensor type into the image sensor, pH sensor, pressure sensor, temperature sensor, and other types of sensor.
The Diagnostics Segment is Expected to hold the Highest Market Share.
By application, the diagnostics segment of the market is believed to have the largest market size in 2018. The reason for this is due to the presence of capsule endoscopes for nearly two decades in the market. Capsule endoscopy has established itself as an effective and precise way of endoscopic imaging. As such, the reimbursements for capsule endoscopy procedures are also available in the developed markets. Furthermore, the increasing prevalence of gastrointestinal disorders is also expected to fuel the expansion of capsule endoscopy and is leading to the growth of the diagnosis segment of the market.
North America Dominates the Market and is Expected to do the Same over the Forecast Period
North America currently dominates the market for ingestible sensors and is expected to continue its stronghold for a few more years. This region is expected to retain its market share in the future owing to the increasing number of diseases and rising geriatric population. The United States holds the majority of the market in the North America region; this is due to the presence of reimbursements, high healthcare expenditure, and an increasing focus on preventive care in place of a curative approach.
North America currently dominates the market for ingestible sensors and is expected to continue its stronghold for a few more years. This region is expected to retain its market share in the future owing to the increasing number of diseases and rising geriatric population. The United States holds the majority of the market in the North America region; this is due to the presence of reimbursements, high healthcare expenditure and increasing focus on preventive care in place of curative approach.
